However, in general only about 40–60% of migraine patients are significantly helped by these agents [12, 14, 15], which suggests involvement of other factors beyond CGRP in migraine pathophysiology, such as PACAP [16]. The gene discussed is ADCYAP1; the disease is migraine disorder.